ReviewCell communication and signaling : CCS2022
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Adel Naimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
322 papers cite itlatest 60 shown
this paperpooled ittrialcites it